VIELABIO Trademark

Trademark Overview

On Wednesday, May 8, 2019, a trademark application was filed for VIELABIO with the United States Patent and Trademark Office. The USPTO has given the VIELABIO trademark a serial number of 88420346. The federal status of this trademark filing is REGISTERED as of Tuesday, November 24, 2020. This trademark is owned by VIELA BIO, INC.. The VIELABIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of rare autoimmune diseases and disorders
vielabio

General Information

Serial Number88420346
Word MarkVIELABIO
Filing DateWednesday, May 8, 2019
Status700 - REGISTERED
Status DateTuesday, November 24, 2020
Registration Number6206620
Registration DateTuesday, November 24, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 3, 2019

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of rare autoimmune diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 23, 2019
Primary Code005
First Use Anywhere DateThursday, July 30, 2020
First Use In Commerce DateThursday, July 30, 2020

Trademark Owner History

Party NameVIELA BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameVIELA BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameVIELA BIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Thursday, February 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 31, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 24, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, October 21, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 20, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 20, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, October 5, 2020USE AMENDMENT FILED
Tuesday, October 20, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 5, 2020TEAS STATEMENT OF USE RECEIVED
Friday, April 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 1, 2020SOU EXTENSION 1 FILED
Wednesday, April 1, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 14, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 24, 2019ASSIGNED TO EXAMINER
Friday, May 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 11, 2019NEW APPLICATION ENTERED

Related Keywords

vielabio diseases disorders autoimmune rare products treatment pharmaceutical